Companies › VRAX

VIRAX BIOLABS GROUP LTD (VRAX)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001885827 · EDGAR filings · Updated 2026-07-24

VIRAX BIOLABS GROUP LTD (VRAX) has 3 institutional managers reporting positions valued at $202.2K per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Filings this week (1)

• 2026-07-24 — F-3 filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-16 — Foreign issuer report (6-K) filed
• 2026-07-10 — Foreign issuer report (6-K) filed
• 2026-07-09 — Foreign issuer report (6-K) filed
• 2026-07-06 — Annual report (20-F) filed
• 2026-06-24 — Foreign issuer report (6-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, VIRAX BIOLABS GROUP LTD has 3 institutional holders.

Insider activity

Insiders reported 0 transactions (0 buys, 0 sells) across 1 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Related companies

Aptevo Therapeutics Inc (APVO) · BIOMERICA INC (BMRA) · InMed Pharmaceuticals Inc (INM) · IO BIOTECH INC (IOBTQ) · VYOME HOLDINGS INC (HIND) · Biorestorative Therapies Inc (BRTX)